Jens Vinge Nygaard

Dr. Jens Vinge Nygaard

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Journal of Biomechanics
Verified
Journal Article
Closed access
SKSamuel A. Kock
Samuel A. Kock
JNJens Vinge Nygaard
Jens Vinge Nygaard
NENikolaj Eldrup
Nikolaj Eldrup
EFErnst-Torben Fründ
Ernst-Torben Fründ
AKAnette Klærke
Anette Klærke
WKW. Yong Kim
W. Yong Kim

6 January 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MPMartin Bjerregaard Pedersen
Martin Bjerregaard Pedersen
XZXingfei Zhou
Xingfei Zhou
ELEsben Kjær Unmack Larsen
Esben Kjær Unmack Larsen
USUffe Skov Sørensen
Uffe Skov Sørensen
JKJørgen Kjems
Jørgen Kjems
TVThomas Vorup-Jensen
Thomas Vorup-Jensen
The binding of Abs to microbial surfaces followed by complement activation constitutes an important line of defense against infections. In this study, we have investigated the relationship between complement activation and the binding of human IgM Abs to surfaces with different curvatures. IgM Abs to dextran were shown to activate complement potently on dextran-coated particles having a diameter around 250 nm, whereas larger (600 nm) particles were less potent activators. This selectivity regarding particle dimension was also found for complement activation by colloidal substances of microbial origin. Peptidoglycan (PGN) is the major chemical component in the cell wall of Gram-positive bacteria. Fragments of purified PGN with sizes of ∼100 nm promoted complement activation effectively through the classical pathway. By contrast, larger or smaller fragments of PGN did not activate complement strongly. A careful analysis of PGN fragments released during planctonic growth of Staphylococcus aureus showed that these include curvatures that would permit strong IgM-mediated complement activation, whereas the curvature of intact cells would be less effective for such activation. Consistently, we found that the suspended PGN fragments were strong activators of complement through the classical pathway. We suggest that these fragments act as decoy targets for complement activation, providing protection for S. aureus against the host immune response to infection.

1 May 2011 in Acta Biomaterialia
Verified
Journal Article
Closed access
MCMuwan Chen
Muwan Chen
DLDang Q.S. Le
Dang Q.S. Le
ABAnette Baatrup
Anette Baatrup
JNJens Vinge Nygaard
Jens Vinge Nygaard
SHSan Hein
San Hein
CBCody Bünger
Cody Bünger

2 October 2013 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
JJJonas Jensen
Jonas Jensen
JRJan Duedal Rölfing
Jan Duedal Rölfing
DLDang Quang Svend Le
Dang Quang Svend Le
AKAsger Albæk Kristiansen
Asger Albæk Kristiansen
JNJens Vinge Nygaard
Jens Vinge Nygaard
CBCody Eric Bünger
Cody Eric Bünger

1 November 2010 in Molecular Therapy
Verified
Journal Article
Open access
PDF file
MAMorten Ø Andersen
Morten Ø Andersen
JNJens Vinge Nygaard
Jens Vinge Nygaard
JBJorge Burns
Jorge Burns
MRMerete K Raarup
Merete K Raarup
JNJens R Nyengaard
Jens R Nyengaard
JKJørgen Kjems
Jørgen Kjems
The creation of complex tissues and organs is the ultimate goal in tissue engineering. Engineered morphogenesis necessitates spatially controlled development of multiple cell types within a scaffold implant. We present a novel method to achieve this by adhering nanoparticles containing different small-interfering RNAs (siRNAs) into nanostructured scaffolds. This allows spatial retention of the RNAs within nanopores until their cellular delivery. The released siRNAs were capable of gene silencing BCL2L2 and TRIB2, in mesenchymal stem cells (MSCs), enhancing osteogenic and adipogenic differentiation, respectively. This approach for enhancing a single type of differentiation is immediately applicable to all areas of tissue engineering. Different nanoparticles localized to spatially distinct locations within a single implant allowed two different tissue types to develop in controllable areas of an implant. As a consequence of this, we predict that complex tissues and organs can be engineered by the in situ development of multiple cell types guided by spatially restricted nanoparticles.

5 October 2011 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
BCBjørn Borsøe Christensen
Bjørn Borsøe Christensen
CFCasper Bindzus Foldager
Casper Bindzus Foldager
OHOle Møller Hansen
Ole Møller Hansen
AKAsger Albæk Kristiansen
Asger Albæk Kristiansen
DLDang Quang Svend Le
Dang Quang Svend Le
MLMartin Lind
Martin Lind